25 XP   0   0   10

Shandong Sinobioway Biomedicine Co Ltd
Buy, Hold or Sell?

Let's analyse Shandong Sinobioway Biomedicine Co Ltd together

PenkeI guess you are interested in Shandong Sinobioway Biomedicine Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Shandong Sinobioway Biomedicine Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Shandong Sinobioway Biomedicine Co Ltd

I send you an email if I find something interesting about Shandong Sinobioway Biomedicine Co Ltd.

Quick analysis of Shandong Sinobioway Biomedicine Co Ltd (30 sec.)










What can you expect buying and holding a share of Shandong Sinobioway Biomedicine Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
87.5%

What is your share worth?

Current worth
¥3.81
Expected worth in 1 year
¥3.78
How sure are you?
72.5%

+ What do you gain per year?

Total Gains per Share
¥-0.02
Return On Investment
-0.2%

For what price can you sell your share?

Current Price per Share
¥13.80
Expected price per share
¥12.13 - ¥14.04
How sure are you?
50%

1. Valuation of Shandong Sinobioway Biomedicine Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥13.80

Intrinsic Value Per Share

¥-0.05 - ¥3.06

Total Value Per Share

¥3.76 - ¥6.87

2. Growth of Shandong Sinobioway Biomedicine Co Ltd (5 min.)




Is Shandong Sinobioway Biomedicine Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$347.5m$344.5m-$4.3m-1.3%

How much money is Shandong Sinobioway Biomedicine Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$1.7m-$414.3k-$1.2m-75.7%
Net Profit Margin-21.3%-4.4%--

How much money comes from the company's main activities?

3. Financial Health of Shandong Sinobioway Biomedicine Co Ltd (5 min.)




What can you expect buying and holding a share of Shandong Sinobioway Biomedicine Co Ltd? (5 min.)

Welcome investor! Shandong Sinobioway Biomedicine Co Ltd's management wants to use your money to grow the business. In return you get a share of Shandong Sinobioway Biomedicine Co Ltd.

What can you expect buying and holding a share of Shandong Sinobioway Biomedicine Co Ltd?

First you should know what it really means to hold a share of Shandong Sinobioway Biomedicine Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Shandong Sinobioway Biomedicine Co Ltd is ¥13.80. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Shandong Sinobioway Biomedicine Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Shandong Sinobioway Biomedicine Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.81. Based on the TTM, the Book Value Change Per Share is ¥-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Shandong Sinobioway Biomedicine Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.020.1%0.000.0%0.000.0%0.000.0%0.010.0%
Usd Book Value Change Per Share0.020.1%0.000.0%0.000.0%0.000.0%0.010.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.020.1%0.000.0%0.000.0%0.000.0%0.010.1%
Usd Price Per Share2.34-2.33-2.53-2.06-2.57-
Price to Earnings Ratio33.45--44.23-436.09-63.34-82.35-
Price-to-Total Gains Ratio113.74--266.62-560.95-39.92-128.46-
Price to Book Ratio4.44-4.52-4.86-4.03-7.44-
Price-to-Total Gains Ratio113.74--266.62-560.95-39.92-128.46-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.90578
Number of shares524
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (524 shares)-0.39-1.39
Gains per Year (524 shares)-1.54-5.57
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11-2-123-9-16
22-5-147-18-22
32-7-1610-27-28
43-9-1814-36-34
54-12-2017-45-40
65-14-2221-54-46
75-16-2424-63-52
86-18-2628-72-58
97-21-2831-81-64
108-23-3035-91-70

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%7.05.00.058.3%10.010.00.050.0%29.011.00.072.5%41.011.00.078.8%
Book Value Change Per Share1.03.00.025.0%7.05.00.058.3%9.011.00.045.0%27.013.00.067.5%37.015.00.071.2%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%35.00.05.087.5%45.00.07.086.5%
Total Gains per Share1.03.00.025.0%7.05.00.058.3%10.010.00.050.0%29.011.00.072.5%40.012.00.076.9%

Fundamentals of Shandong Sinobioway Biomedicine Co Ltd

About Shandong Sinobioway Biomedicine Co Ltd

Shandong Sinobioway Biomedicine Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates in China. The company manufactures and supplies trimethyl orthoformate, triethyl orthoformate, trimethyl orthoacetate, phosphorous acid, ethyl formate, and trimethyl acetate and its by-products. It also offers Anfulan, a human interferon a2b injection; Jiefu, a human interferon a2b spray; Enjingfu, a mouse nerve growth factor for injection; and Bellaph, a combined hepatitis A and B vaccine. In addition, the company is involved in biopharmaceutical research and development services, including cell line development and cell bank building, cell culture process development, protein purification process development, preparation prescription and process development, analysis and detection method development, and quality research. Further, it provides biopharmaceutical production services, such as preclinical, clinical phase I/II/III and commercial manufacturing; and other services, including regulatory service support and drug registration affairs. Shandong Sinobioway Biomedicine Co., Ltd. was founded in 2000 and is based in Shenzhen, China. Shandong Sinobioway Biomedicine Co., Ltd. is the subsidiary of Shenzhen Yilian Technology Co., Ltd.

Fundamental data was last updated by Penke on 2024-04-14 17:56:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Shandong Sinobioway Biomedicine Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Shandong Sinobioway Biomedicine Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Shandong Sinobioway Biomedicine Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 64.6% means that ¥0.65 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Shandong Sinobioway Biomedicine Co Ltd:

  • The MRQ is 64.6%. The company is making a huge profit. +2
  • The TTM is -21.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ64.6%TTM-21.3%+85.9%
TTM-21.3%YOY-4.4%-16.8%
TTM-21.3%5Y-3.9%-17.3%
5Y-3.9%10Y10.9%-14.8%
1.1.2. Return on Assets

Shows how efficient Shandong Sinobioway Biomedicine Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Shandong Sinobioway Biomedicine Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.0% Return on Assets means that Shandong Sinobioway Biomedicine Co Ltd generated ¥0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Shandong Sinobioway Biomedicine Co Ltd:

  • The MRQ is 3.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is -0.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ3.0%TTM-0.4%+3.4%
TTM-0.4%YOY-0.1%-0.3%
TTM-0.4%5Y0.1%-0.5%
5Y0.1%10Y1.4%-1.3%
1.1.3. Return on Equity

Shows how efficient Shandong Sinobioway Biomedicine Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Shandong Sinobioway Biomedicine Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.5% Return on Equity means Shandong Sinobioway Biomedicine Co Ltd generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Shandong Sinobioway Biomedicine Co Ltd:

  • The MRQ is 3.5%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -0.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ3.5%TTM-0.5%+4.0%
TTM-0.5%YOY-0.1%-0.4%
TTM-0.5%5Y0.0%-0.6%
5Y0.0%10Y1.5%-1.5%

1.2. Operating Efficiency of Shandong Sinobioway Biomedicine Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Shandong Sinobioway Biomedicine Co Ltd is operating .

  • Measures how much profit Shandong Sinobioway Biomedicine Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Shandong Sinobioway Biomedicine Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -10.7% means the company generated ¥-0.11  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Shandong Sinobioway Biomedicine Co Ltd:

  • The MRQ is -10.7%. The company is operating very inefficient. -2
  • The TTM is -23.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-10.7%TTM-23.4%+12.7%
TTM-23.4%YOY-51.7%+28.4%
TTM-23.4%5Y-43.3%+20.0%
5Y-43.3%10Y-21.3%-22.0%
1.2.2. Operating Ratio

Measures how efficient Shandong Sinobioway Biomedicine Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.26 means that the operating costs are ¥1.26 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Shandong Sinobioway Biomedicine Co Ltd:

  • The MRQ is 1.263. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.471. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.263TTM1.471-0.208
TTM1.471YOY1.804-0.334
TTM1.4715Y1.678-0.207
5Y1.67810Y1.043+0.635

1.3. Liquidity of Shandong Sinobioway Biomedicine Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Shandong Sinobioway Biomedicine Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.61 means the company has ¥2.61 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Shandong Sinobioway Biomedicine Co Ltd:

  • The MRQ is 2.606. The company is able to pay all its short-term debts. +1
  • The TTM is 1.717. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.606TTM1.717+0.890
TTM1.717YOY1.936-0.219
TTM1.7175Y4.157-2.441
5Y4.15710Y2.335+1.822
1.3.2. Quick Ratio

Measures if Shandong Sinobioway Biomedicine Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Shandong Sinobioway Biomedicine Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.94 means the company can pay off ¥0.94 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Shandong Sinobioway Biomedicine Co Ltd:

  • The MRQ is 0.941. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.692. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.941TTM0.692+0.248
TTM0.692YOY0.948-0.255
TTM0.6925Y1.465-0.773
5Y1.46510Y2.560-1.095

1.4. Solvency of Shandong Sinobioway Biomedicine Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Shandong Sinobioway Biomedicine Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Shandong Sinobioway Biomedicine Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.10 means that Shandong Sinobioway Biomedicine Co Ltd assets are financed with 10.1% credit (debt) and the remaining percentage (100% - 10.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Shandong Sinobioway Biomedicine Co Ltd:

  • The MRQ is 0.101. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.118. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.101TTM0.118-0.017
TTM0.118YOY0.106+0.012
TTM0.1185Y0.173-0.055
5Y0.17310Y0.146+0.027
1.4.2. Debt to Equity Ratio

Measures if Shandong Sinobioway Biomedicine Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Shandong Sinobioway Biomedicine Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 11.7% means that company has ¥0.12 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Shandong Sinobioway Biomedicine Co Ltd:

  • The MRQ is 0.117. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.140. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.117TTM0.140-0.022
TTM0.140YOY0.123+0.016
TTM0.1405Y0.232-0.093
5Y0.23210Y0.194+0.038

2. Market Valuation of Shandong Sinobioway Biomedicine Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Shandong Sinobioway Biomedicine Co Ltd generates.

  • Above 15 is considered overpriced but always compare Shandong Sinobioway Biomedicine Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 33.45 means the investor is paying ¥33.45 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Shandong Sinobioway Biomedicine Co Ltd:

  • The EOD is 27.268. Based on the earnings, the company is overpriced. -1
  • The MRQ is 33.453. Based on the earnings, the company is overpriced. -1
  • The TTM is -44.233. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD27.268MRQ33.453-6.185
MRQ33.453TTM-44.233+77.685
TTM-44.233YOY436.087-480.320
TTM-44.2335Y63.339-107.571
5Y63.33910Y82.352-19.014
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Shandong Sinobioway Biomedicine Co Ltd:

  • The EOD is 38.377. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 47.081. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is -80.533. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD38.377MRQ47.081-8.704
MRQ47.081TTM-80.533+127.614
TTM-80.533YOY-147.250+66.717
TTM-80.5335Y-62.323-18.210
5Y-62.32310Y13.316-75.639
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Shandong Sinobioway Biomedicine Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Shandong Sinobioway Biomedicine Co Ltd:

  • The EOD is 3.618. Based on the equity, the company is fair priced.
  • The MRQ is 4.439. Based on the equity, the company is fair priced.
  • The TTM is 4.517. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.618MRQ4.439-0.821
MRQ4.439TTM4.517-0.078
TTM4.517YOY4.856-0.340
TTM4.5175Y4.027+0.490
5Y4.02710Y7.437-3.410
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Shandong Sinobioway Biomedicine Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.146-0.008+105%-0.002+101%-0.031+121%0.068+114%
Book Value Per Share--3.8143.733+2%3.782+1%3.784+1%3.360+14%
Current Ratio--2.6061.717+52%1.936+35%4.157-37%2.335+12%
Debt To Asset Ratio--0.1010.118-14%0.106-5%0.173-42%0.146-31%
Debt To Equity Ratio--0.1170.140-16%0.123-5%0.232-50%0.194-40%
Dividend Per Share--0.0030.003+8%0.003-12%0.012-76%0.023-88%
Eps--0.127-0.023+118%-0.005+104%0.003+4760%0.044+185%
Free Cash Flow Per Share--0.090-0.016+118%-0.047+152%-0.058+164%0.005+1560%
Free Cash Flow To Equity Per Share--0.029-0.048+263%-0.008+127%-0.154+623%0.032-7%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--3.058--------
Intrinsic Value_10Y_min---0.052--------
Intrinsic Value_1Y_max--0.063--------
Intrinsic Value_1Y_min---0.101--------
Intrinsic Value_3Y_max--0.375--------
Intrinsic Value_3Y_min---0.223--------
Intrinsic Value_5Y_max--0.910--------
Intrinsic Value_5Y_min---0.254--------
Market Cap9104356800.000-23%11169330480.00011116551600.000+0%12106155600.000-8%9817531416.000+14%12270535684.500-9%
Net Profit Margin--0.646-0.213+133%-0.044+107%-0.039+106%0.109+495%
Operating Margin---0.107-0.234+119%-0.517+384%-0.433+306%-0.213+100%
Operating Ratio--1.2631.471-14%1.804-30%1.678-25%1.043+21%
Pb Ratio3.618-23%4.4394.517-2%4.856-9%4.027+10%7.437-40%
Pe Ratio27.268-23%33.453-44.233+232%436.087-92%63.339-47%82.352-59%
Price Per Share13.800-23%16.93016.850+0%18.350-8%14.881+14%18.599-9%
Price To Free Cash Flow Ratio38.377-23%47.081-80.533+271%-147.250+413%-62.323+232%13.316+254%
Price To Total Gains Ratio92.710-23%113.738-266.617+334%560.945-80%39.923+185%128.463-11%
Quick Ratio--0.9410.692+36%0.948-1%1.465-36%2.560-63%
Return On Assets--0.030-0.004+115%-0.001+104%0.001+2548%0.014+108%
Return On Equity--0.035-0.005+116%-0.001+104%0.000+10962%0.015+124%
Total Gains Per Share--0.149-0.005+104%0.002+8559%-0.019+113%0.091+63%
Usd Book Value--347513069.189340139764.376+2%344537908.088+1%344785375.013+1%306114814.221+14%
Usd Book Value Change Per Share--0.020-0.001+105%0.000+101%-0.004+121%0.009+114%
Usd Book Value Per Share--0.5270.516+2%0.522+1%0.523+1%0.464+14%
Usd Dividend Per Share--0.0000.000+8%0.000-12%0.002-76%0.003-88%
Usd Eps--0.017-0.003+118%-0.001+104%0.000+4760%0.006+185%
Usd Free Cash Flow--8190599.617-1451930.607+118%-4260211.182+152%-5254356.685+164%493004.073+1561%
Usd Free Cash Flow Per Share--0.012-0.002+118%-0.006+152%-0.008+164%0.001+1560%
Usd Free Cash Flow To Equity Per Share--0.004-0.007+263%-0.001+127%-0.021+623%0.004-7%
Usd Market Cap1257311674.080-23%1542484539.2881535195775.960+0%1671860088.360-8%1355801088.550+14%1694560978.029-9%
Usd Price Per Share1.906-23%2.3382.327+0%2.534-8%2.055+14%2.569-9%
Usd Profit--11527292.557-1706462.794+115%-414331.407+104%175987.232+6450%4012851.139+187%
Usd Revenue--17839761.48614496970.042+23%12513604.513+43%14896205.628+20%21462246.028-17%
Usd Total Gains Per Share--0.021-0.001+104%0.000+8559%-0.003+113%0.013+63%
 EOD+4 -4MRQTTM+32 -3YOY+27 -85Y+28 -710Y+23 -12

3.2. Fundamental Score

Let's check the fundamental score of Shandong Sinobioway Biomedicine Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1527.268
Price to Book Ratio (EOD)Between0-13.618
Net Profit Margin (MRQ)Greater than00.646
Operating Margin (MRQ)Greater than0-0.107
Quick Ratio (MRQ)Greater than10.941
Current Ratio (MRQ)Greater than12.606
Debt to Asset Ratio (MRQ)Less than10.101
Debt to Equity Ratio (MRQ)Less than10.117
Return on Equity (MRQ)Greater than0.150.035
Return on Assets (MRQ)Greater than0.050.030
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Shandong Sinobioway Biomedicine Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.604
Ma 20Greater thanMa 5012.975
Ma 50Greater thanMa 10012.122
Ma 100Greater thanMa 20012.856
OpenGreater thanClose14.000
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,799,066
Total Liabilities282,679
Total Stockholder Equity2,412,637
 As reported
Total Liabilities 282,679
Total Stockholder Equity+ 2,412,637
Total Assets = 2,799,066

Assets

Total Assets2,799,066
Total Current Assets676,898
Long-term Assets2,122,169
Total Current Assets
Cash And Cash Equivalents 318,052
Net Receivables 244,285
Inventory 90,634
Other Current Assets 23,927
Total Current Assets  (as reported)676,898
Total Current Assets  (calculated)676,898
+/- 0
Long-term Assets
Property Plant Equipment 650,150
Intangible Assets 119,953
Other Assets 38,106
Long-term Assets  (as reported)2,122,169
Long-term Assets  (calculated)808,208
+/- 1,313,960

Liabilities & Shareholders' Equity

Total Current Liabilities259,739
Long-term Liabilities22,940
Total Stockholder Equity2,412,637
Total Current Liabilities
Short Long Term Debt 117,200
Accounts payable 47,295
Other Current Liabilities 87,878
Total Current Liabilities  (as reported)259,739
Total Current Liabilities  (calculated)252,373
+/- 7,365
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt858
Other Liabilities 22,082
Long-term Liabilities  (as reported)22,940
Long-term Liabilities  (calculated)22,940
+/- 0
Total Stockholder Equity
Common Stock229,145
Retained Earnings 1,315,879
Total Stockholder Equity (as reported)2,412,637
Total Stockholder Equity (calculated)1,545,024
+/- 867,612
Other
Capital Stock229,145
Common Stock Shares Outstanding 659,736
Net Invested Capital 2,529,837
Net Tangible Assets 2,292,684
Net Working Capital 417,159
Property Plant and Equipment Gross 650,150



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302009-12-312008-12-312007-12-31
> Total Assets 
95,540
143,530
164,946
194,062
209,680
235,012
690,729
669,265
690,193
717,673
703,478
712,275
729,025
758,131
734,005
746,012
773,799
799,012
765,961
766,086
769,487
806,688
825,888
2,406,480
2,415,775
2,453,118
2,452,863
2,490,816
2,687,542
2,724,129
2,822,575
3,697,634
3,998,440
4,357,811
4,300,382
4,270,893
4,298,453
3,972,384
4,030,299
3,881,504
3,472,316
3,363,144
3,276,675
2,557,043
2,444,963
2,490,694
2,582,258
2,780,005
2,756,080
2,757,328
2,788,849
2,867,578
2,857,916
2,765,096
2,749,586
2,799,066
2,799,0662,749,5862,765,0962,857,9162,867,5782,788,8492,757,3282,756,0802,780,0052,582,2582,490,6942,444,9632,557,0433,276,6753,363,1443,472,3163,881,5044,030,2993,972,3844,298,4534,270,8934,300,3824,357,8113,998,4403,697,6342,822,5752,724,1292,687,5422,490,8162,452,8632,453,1182,415,7752,406,480825,888806,688769,487766,086765,961799,012773,799746,012734,005758,131729,025712,275703,478717,673690,193669,265690,729235,012209,680194,062164,946143,53095,540
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,701,854
2,793,569
2,523,422
2,308,440
2,038,716
1,872,389
1,801,132
1,728,430
1,599,072
858,011
766,163
751,408
679,284
635,287
568,452
538,951
515,862
459,707
518,362
405,646
444,204
676,898
676,898444,204405,646518,362459,707515,862538,951568,452635,287679,284751,408766,163858,0111,599,0721,728,4301,801,1321,872,3892,038,7162,308,4402,523,4222,793,5692,701,8540000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,850,161
1,866,352
1,545,695
1,289,305
1,164,937
1,016,349
991,195
901,056
1,023,564
313,646
284,151
276,346
215,458
207,662
187,797
159,214
146,704
141,779
183,803
111,066
84,584
318,052
318,05284,584111,066183,803141,779146,704159,214187,797207,662215,458276,346284,151313,6461,023,564901,056991,1951,016,3491,164,9371,289,3051,545,6951,866,3521,850,1610000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
130,000
0
130,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000130,0000130,000000000000000000000000000000000000000
       Net Receivables 
18,631
14,874
40,405
32,189
28,176
39,242
27,133
28,853
37,224
49,573
65,200
65,799
54,382
77,397
44,148
56,361
75,825
109,792
94,337
82,829
74,515
82,040
87,438
402,993
476,314
470,120
471,592
541,118
673,916
685,470
651,252
637,911
819,872
707,741
770,312
851,562
658,239
460,912
481,936
474,224
548,830
545,351
443,815
411,363
370,524
346,959
362,052
322,012
286,446
271,739
246,722
212,271
195,977
134,964
253,515
244,285
244,285253,515134,964195,977212,271246,722271,739286,446322,012362,052346,959370,524411,363443,815545,351548,830474,224481,936460,912658,239851,562770,312707,741819,872637,911651,252685,470673,916541,118471,592470,120476,314402,99387,43882,04074,51582,82994,337109,79275,82556,36144,14877,39754,38265,79965,20049,57337,22428,85327,13339,24228,17632,18940,40514,87418,631
       Other Current Assets 
5,590
1,052
10,803
7,239
7,262
7,948
16,460
6,897
6,422
6,797
12,795
20,967
4,437
4,294
4,389
6,399
6,982
5,241
6,808
7,774
11,773
20,168
17,869
22,796
7,890
9,956
10,206
12,998
7,988
12,946
17,624
7,325
5,295
7,780
31,454
29,536
147,358
266,761
153,685
159,673
64,832
210,369
51,834
52,666
40,620
56,640
38,234
40,601
29,876
36,009
34,939
28,814
58,539
11,319
15,761
23,927
23,92715,76111,31958,53928,81434,93936,00929,87640,60138,23456,64040,62052,66651,834210,36964,832159,673153,685266,761147,35829,53631,4547,7805,2957,32517,62412,9467,98812,99810,2069,9567,89022,79617,86920,16811,7737,7746,8085,2416,9826,3994,3894,2944,43720,96712,7956,7976,4226,89716,4607,9487,2627,23910,8031,0525,590
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,663,943
1,991,583
2,009,115
1,667,574
1,634,714
1,677,603
1,699,031
1,678,800
1,739,286
1,902,975
2,144,718
2,187,627
2,218,377
2,272,987
2,407,871
2,339,553
2,359,450
2,305,382
2,122,169
2,122,1692,305,3822,359,4502,339,5532,407,8712,272,9872,218,3772,187,6272,144,7181,902,9751,739,2861,678,8001,699,0311,677,6031,634,7141,667,5742,009,1151,991,5831,663,9430000000000000000000000000000000000000
       Property Plant Equipment 
37,586
64,419
63,793
85,606
84,775
47,299
83,796
62,408
106,076
70,755
70,980
87,061
157,953
137,295
146,045
148,237
195,542
160,450
163,667
163,039
162,139
161,705
158,753
478,808
475,957
472,754
469,577
483,118
482,193
473,189
463,446
468,184
504,924
501,296
510,750
510,629
811,181
911,172
809,032
789,083
780,899
778,162
827,975
817,315
684,717
686,898
688,861
682,911
713,763
708,006
699,362
688,183
705,469
690,249
667,007
650,150
650,150667,007690,249705,469688,183699,362708,006713,763682,911688,861686,898684,717817,315827,975778,162780,899789,083809,032911,172811,181510,629510,750501,296504,924468,184463,446473,189482,193483,118469,577472,754475,957478,808158,753161,705162,139163,039163,667160,450195,542148,237146,045137,295157,95387,06170,98070,755106,07662,40883,79647,29984,77585,60663,79364,41937,586
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
193,254
193,254
193,254
193,254
193,254
193,254
193,254
193,254
193,254
183,032
183,340
183,032
183,032
20,429
20,429
20,429
20,429
20,429
20,429
20,429
20,429
0
0
0
0
0
0
0
0
0
0
0
0
00000000000020,42920,42920,42920,42920,42920,42920,42920,429183,032183,032183,340183,032193,254193,254193,254193,254193,254193,254193,254193,254193,25400000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
609,331
308,577
434,744
434,744
497,982
528,809
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000528,809497,982434,744434,744308,577609,3310000000000000000000000000000000000
       Intangible Assets 
1,652
19,296
18,861
37,246
37,043
36,840
36,637
36,434
37
36,064
35,859
35,654
30
35,244
35,040
34,835
22
34,425
34,220
34,015
33,810
33,606
33,401
292,738
292,042
290,893
289,993
288,947
287,681
286,719
285,519
284,351
297,793
296,303
111,127
110,030
114,502
112,509
34,188
108,528
224,811
222,840
152,131
149,569
144,547
141,984
139,631
136,872
134,290
132,220
130,159
128,075
126,321
124,176
122,050
119,953
119,953122,050124,176126,321128,075130,159132,220134,290136,872139,631141,984144,547149,569152,131222,840224,811108,52834,188112,509114,502110,030111,127296,303297,793284,351285,519286,719287,681288,947289,993290,893292,042292,73833,40133,60633,81034,01534,22034,4252234,83535,04035,2443035,65435,85936,0643736,43436,63736,84037,04337,24618,86119,2961,652
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
158,109
528,876
534,192
33,363
17,629
29,800
828,164
65,458
69,846
60,728
66,443
83,364
83,288
83,560
85,999
491
32,821
24,219
24,347
24,34724,21932,82149185,99983,56083,28883,36466,44360,72869,84665,458828,16429,80017,62933,363534,192528,876158,1090000000000000000000000000000000000000
> Total Liabilities 
11,601
27,407
35,240
34,738
32,338
36,413
54,869
18,340
17,914
75,574
35,477
25,894
24,615
31,438
37,702
30,044
35,492
34,184
46,868
28,722
20,083
30,146
25,135
365,433
271,921
235,380
195,373
121,480
160,160
118,607
117,939
895,279
1,078,853
1,356,022
1,376,967
1,339,365
1,471,423
1,155,133
1,171,735
996,934
1,024,068
963,563
975,460
271,423
254,328
276,173
249,487
238,657
286,755
283,234
290,282
330,189
389,460
318,019
329,522
282,679
282,679329,522318,019389,460330,189290,282283,234286,755238,657249,487276,173254,328271,423975,460963,5631,024,068996,9341,171,7351,155,1331,471,4231,339,3651,376,9671,356,0221,078,853895,279117,939118,607160,160121,480195,373235,380271,921365,43325,13530,14620,08328,72246,86834,18435,49230,04437,70231,43824,61525,89435,47775,57417,91418,34054,86936,41332,33834,73835,24027,40711,601
   > Total Current Liabilities 
11,601
27,407
35,240
34,738
32,338
36,413
54,869
18,340
17,914
73,374
33,277
23,694
22,415
29,238
35,502
27,844
33,292
31,984
44,668
26,522
17,883
27,946
22,935
329,512
235,227
199,306
160,414
87,466
128,386
87,647
88,011
75,210
256,839
533,566
555,391
517,397
563,625
252,324
273,704
203,681
239,515
245,117
279,036
197,551
206,867
229,214
203,030
192,702
258,539
255,094
262,828
312,916
364,280
293,220
305,577
259,739
259,739305,577293,220364,280312,916262,828255,094258,539192,702203,030229,214206,867197,551279,036245,117239,515203,681273,704252,324563,625517,397555,391533,566256,83975,21088,01187,647128,38687,466160,414199,306235,227329,51222,93527,94617,88326,52244,66831,98433,29227,84435,50229,23822,41523,69433,27773,37417,91418,34054,86936,41332,33834,73835,24027,40711,601
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
130,000
130,000
130,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000130,000130,000130,0000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
130,000
130,000
130,000
150,000
150,500
190,000
124,024
118,500
159,500
130,500
130,500
151,536
167,500
167,500
167,300
150,418
147,000
155,230
117,200
117,200155,230147,000150,418167,300167,500167,500151,536130,500130,500159,500118,500124,024190,000150,500150,000130,000130,000130,0000000000000000000000000000000000000000
       Accounts payable 
2,202
3,179
5,124
6,074
3,713
5,533
3,793
8,112
7,360
7,379
10,680
13,255
14,819
18,019
14,263
14,451
20,231
15,998
17,252
12,373
9,514
12,437
7,058
23,471
27,923
25,253
23,350
24,942
34,468
21,354
22,691
14,026
26,269
13,380
16,543
16,088
32,699
36,839
52,956
34,645
30,177
31,024
17,041
25,773
14,456
12,907
15,173
16,191
42,132
49,284
61,151
36,125
43,637
33,836
46,550
47,295
47,29546,55033,83643,63736,12561,15149,28442,13216,19115,17312,90714,45625,77317,04131,02430,17734,64552,95636,83932,69916,08816,54313,38026,26914,02622,69121,35434,46824,94223,35025,25327,92323,4717,05812,4379,51412,37317,25215,99820,23114,45114,26318,01914,81913,25510,6807,3797,3608,1123,7935,5333,7136,0745,1243,1792,202
       Other Current Liabilities 
9,399
4,228
10,116
8,664
8,625
10,880
51,076
10,228
10,554
65,995
22,597
10,439
7,596
11,219
21,239
13,393
13,061
15,986
27,416
14,149
8,369
15,509
15,877
85,828
94,655
70,054
56,615
62,524
93,468
65,792
64,819
60,684
130,070
70,186
19,349
42,751
23,846
45,085
19,074
28,337
20,744
31,060
20,342
38,808
20,751
30,477
24,052
31,038
28,977
20,544
7,120
87,583
143,299
1,189
82,240
87,878
87,87882,2401,189143,29987,5837,12020,54428,97731,03824,05230,47720,75138,80820,34231,06020,74428,33719,07445,08523,84642,75119,34970,186130,07060,68464,81965,79293,46862,52456,61570,05494,65585,82815,87715,5098,36914,14927,41615,98613,06113,39321,23911,2197,59610,43922,59765,99510,55410,22851,07610,8808,6258,66410,1164,2289,399
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
902,810
898,031
793,253
788,201
718,447
696,424
73,872
47,461
46,959
46,457
45,955
28,216
28,140
27,454
17,273
25,180
24,799
23,946
22,940
22,94023,94624,79925,18017,27327,45428,14028,21645,95546,45746,95947,46173,872696,424718,447788,201793,253898,031902,8100000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
2,200
2,200
2,200
2,200
2,200
2,200
2,200
2,200
2,200
2,200
2,200
2,200
2,200
2,200
17,735
18,978
18,673
18,368
17,263
16,958
16,958
16,349
16,044
14,614
14,309
29,407
29,566
27,391
27,137
26,000
25,305
22,036
23,915
20,856
20,266
19,693
19,190
18,688
18,186
18,416
18,340
17,654
17,273
23,707
0
22,929
22,082
22,08222,929023,70717,27317,65418,34018,41618,18618,68819,19019,69320,26620,85623,91522,03625,30526,00027,13727,39129,56629,40714,30914,61416,04416,34916,95816,95817,26318,36818,67318,97817,7352,2002,2002,2002,2002,2002,2002,2002,2002,2002,2002,2002,2002,2002,200000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,655
6,942
6,742
6,077
5,412
10,972
10,768
10,659
9,574
8,649
7,724
6,800
5,875
5,079
7,783
7,119
6,456
5,792
5,196
0
4,795
4,133
4,1334,79505,1965,7926,4567,1197,7835,0795,8756,8007,7248,6499,57410,65910,76810,9725,4126,0776,7426,9427,6550000000000000000000000000000000000
> Total Stockholder Equity
83,939
116,122
129,706
159,323
177,342
198,599
635,860
650,926
672,279
642,099
668,001
686,381
704,410
726,694
696,303
715,967
738,307
764,828
719,093
737,364
749,404
776,543
800,753
1,980,578
2,084,773
2,163,093
2,204,730
2,321,691
2,469,482
2,546,731
2,646,275
2,741,794
2,857,893
2,940,266
2,863,487
2,870,486
2,762,104
2,749,177
2,787,759
2,811,424
2,375,470
2,312,649
2,219,555
2,205,913
2,117,209
2,141,600
2,255,130
2,464,662
2,388,211
2,390,045
2,412,167
2,452,661
2,373,521
2,352,015
2,322,225
2,412,637
2,412,6372,322,2252,352,0152,373,5212,452,6612,412,1672,390,0452,388,2112,464,6622,255,1302,141,6002,117,2092,205,9132,219,5552,312,6492,375,4702,811,4242,787,7592,749,1772,762,1042,870,4862,863,4872,940,2662,857,8932,741,7942,646,2752,546,7312,469,4822,321,6912,204,7302,163,0932,084,7731,980,578800,753776,543749,404737,364719,093764,828738,307715,967696,303726,694704,410686,381668,001642,099672,279650,926635,860198,599177,342159,323129,706116,12283,939
   Common Stock
10,000
58,000
58,000
81,200
81,200
81,200
108,280
108,280
108,280
108,280
108,280
108,280
108,280
108,280
140,764
140,764
140,764
140,764
140,764
140,764
140,764
140,764
140,764
229,145
229,145
229,145
229,145
229,145
229,145
229,145
229,145
229,145
229,145
229,145
229,145
229,145
229,145
229,145
229,145
229,145
229,145
229,145
229,145
229,145
229,145
229,145
229,145
229,145
229,145
229,145
229,145
229,145
229,145
0
229,145
229,145
229,145229,1450229,145229,145229,145229,145229,145229,145229,145229,145229,145229,145229,145229,145229,145229,145229,145229,145229,145229,145229,145229,145229,145229,145229,145229,145229,145229,145229,145229,145229,145229,145140,764140,764140,764140,764140,764140,764140,764140,764140,764108,280108,280108,280108,280108,280108,280108,280108,28081,20081,20081,20058,00058,00010,000
   Retained Earnings 
49,887
45,818
23,162
52,779
63,772
85,029
51,017
66,083
80,739
50,558
76,460
94,841
104,242
126,526
96,136
115,800
129,336
189,584
143,849
162,121
174,160
201,299
225,509
396,715
500,916
579,235
620,872
737,833
885,624
962,874
1,062,417
1,157,937
1,274,036
1,356,408
1,279,630
1,286,629
1,178,247
1,023,999
1,062,581
1,086,245
1,225,708
1,157,152
1,133,355
1,119,714
1,029,773
1,054,165
1,167,695
1,377,226
1,300,775
1,302,610
1,324,732
1,365,226
1,286,085
1,113,232
1,232,328
1,315,879
1,315,8791,232,3281,113,2321,286,0851,365,2261,324,7321,302,6101,300,7751,377,2261,167,6951,054,1651,029,7731,119,7141,133,3551,157,1521,225,7081,086,2451,062,5811,023,9991,178,2471,286,6291,279,6301,356,4081,274,0361,157,9371,062,417962,874885,624737,833620,872579,235500,916396,715225,509201,299174,160162,121143,849189,584129,336115,80096,136126,526104,24294,84176,46050,55880,73966,08351,01785,02963,77252,77923,16245,81849,887
   Capital Surplus 00000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 00000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue419,898
Cost of Revenue-75,779
Gross Profit344,119344,119
 
Operating Income (+$)
Gross Profit344,119
Operating Expense-533,555
Operating Income-113,657-189,436
 
Operating Expense (+$)
Research Development46,344
Selling General Administrative363,975
Selling And Marketing Expenses-
Operating Expense533,555410,319
 
Net Interest Income (+$)
Interest Income3,023
Interest Expense-9,411
Other Finance Cost-2,879
Net Interest Income-9,267
 
Pretax Income (+$)
Operating Income-113,657
Net Interest Income-9,267
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-15,786-113,657
EBIT - interestExpense = -9,411
-49,427
-40,016
Interest Expense9,411
Earnings Before Interest and Taxes (EBIT)--6,376
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-15,786
Tax Provision-14,618
Net Income From Continuing Ops-30,404-30,404
Net Income-49,427
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-9,267
 

Technical Analysis of Shandong Sinobioway Biomedicine Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Shandong Sinobioway Biomedicine Co Ltd. The general trend of Shandong Sinobioway Biomedicine Co Ltd is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Shandong Sinobioway Biomedicine Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Shandong Sinobioway Biomedicine Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 13.81 < 13.92 < 14.04.

The bearish price targets are: 12.30 > 12.24 > 12.13.

Tweet this
Shandong Sinobioway Biomedicine Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Shandong Sinobioway Biomedicine Co Ltd. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shandong Sinobioway Biomedicine Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Shandong Sinobioway Biomedicine Co Ltd. The current macd is 0.28279778.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Shandong Sinobioway Biomedicine Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Shandong Sinobioway Biomedicine Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Shandong Sinobioway Biomedicine Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Shandong Sinobioway Biomedicine Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartShandong Sinobioway Biomedicine Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Shandong Sinobioway Biomedicine Co Ltd. The current adx is 16.52.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Shandong Sinobioway Biomedicine Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Shandong Sinobioway Biomedicine Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Shandong Sinobioway Biomedicine Co Ltd. The current sar is 12.16.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Shandong Sinobioway Biomedicine Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Shandong Sinobioway Biomedicine Co Ltd. The current rsi is 64.60. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Shandong Sinobioway Biomedicine Co Ltd Daily Relative Strength Index (RSI) ChartShandong Sinobioway Biomedicine Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Shandong Sinobioway Biomedicine Co Ltd. The current phase is Overbought in neutral market.

The long score for the Stochastic Oscillator is 5/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Shandong Sinobioway Biomedicine Co Ltd price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Shandong Sinobioway Biomedicine Co Ltd Daily Stochastic Oscillator ChartShandong Sinobioway Biomedicine Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Shandong Sinobioway Biomedicine Co Ltd. The current cci is 125.65.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Shandong Sinobioway Biomedicine Co Ltd Daily Commodity Channel Index (CCI) ChartShandong Sinobioway Biomedicine Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Shandong Sinobioway Biomedicine Co Ltd. The current cmo is 40.43.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Shandong Sinobioway Biomedicine Co Ltd Daily Chande Momentum Oscillator (CMO) ChartShandong Sinobioway Biomedicine Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Shandong Sinobioway Biomedicine Co Ltd. The current willr is -18.1372549.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Shandong Sinobioway Biomedicine Co Ltd Daily Williams %R ChartShandong Sinobioway Biomedicine Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Shandong Sinobioway Biomedicine Co Ltd.

Shandong Sinobioway Biomedicine Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Shandong Sinobioway Biomedicine Co Ltd. The current atr is 0.56639837.

Shandong Sinobioway Biomedicine Co Ltd Daily Average True Range (ATR) ChartShandong Sinobioway Biomedicine Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Shandong Sinobioway Biomedicine Co Ltd. The current obv is 155,211,123.

Shandong Sinobioway Biomedicine Co Ltd Daily On-Balance Volume (OBV) ChartShandong Sinobioway Biomedicine Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Shandong Sinobioway Biomedicine Co Ltd. The current mfi is 56.68.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Shandong Sinobioway Biomedicine Co Ltd Daily Money Flow Index (MFI) ChartShandong Sinobioway Biomedicine Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Shandong Sinobioway Biomedicine Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

Shandong Sinobioway Biomedicine Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Shandong Sinobioway Biomedicine Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.604
Ma 20Greater thanMa 5012.975
Ma 50Greater thanMa 10012.122
Ma 100Greater thanMa 20012.856
OpenGreater thanClose14.000
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Shandong Sinobioway Biomedicine Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Shandong Sinobioway Biomedicine Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Shandong Sinobioway Biomedicine Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Shandong Sinobioway Biomedicine Co Ltd

I send you an email if I find something interesting about Shandong Sinobioway Biomedicine Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Shandong Sinobioway Biomedicine Co Ltd.

Receive notifications about Shandong Sinobioway Biomedicine Co Ltd in your mailbox!